PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Blue light phototherapy kills antibiotic-resistant bacteria, according to new studies

2013-12-16
(Press-News.org) Contact information: Vicki Cohn
vcohn@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Blue light phototherapy kills antibiotic-resistant bacteria, according to new studies

New Rochelle, NY, December16, 2013--Blue light has proven to have powerful bacteria-killing ability in the laboratory. The potent antibacterial effects of irradiation using light in the blue spectra have now also been demonstrated in human and animal tissues. A series of groundbreaking articles that provide compelling evidence of this effect are published in Photomedicine and Laser Surgery, a peer-reviewed journal published by Mary Ann Liebert, Inc., publishers. The articles are available on the Photomedicine and Laser Surgery website.

"Bacterial resistance to drugs poses a major healthcare problem," says Co-Editor-in-Chief Chukuka S. Enwemeka, PhD, Dean, College of Health Sciences, University of Wisconsin--Milwaukee, in the accompanying Editorial "Antimicrobial Blue Light: An Emerging Alternative to Antibiotics," citing the growing number of deadly outbreaks worldwide of methicillin-resistant Staphylococcus aureus (MRSA). The articles in this issue of Photomedicine and Laser Surgery provide evidence that "blue light in the range of 405-470 nm wavelength is bactericidal and has the potential to help stem the ongoing pandemic of MRSA and other bacterial infections."

In the article "Effects of Photodynamic Therapy on Gram-Positive and Gram-Negative Bacterial Biofilms by Bioluminescence Imaging and Scanning Electron Microscopic Analysis," Aguinaldo S. Garcez, PhD and coauthors show that photodynamic therapy and methylene blue delivered directly into the root canal of a human tooth infected with a bacterial biofilm was able to destroy both Gram-positive and Gram-negative bacteria, disrupt the biofilms, and reduce the number of bacteria adhering to the tooth.

Raymond J. Lanzafame, MD, MBA, and colleagues demonstrated significantly greater bacterial reduction in the treatment of pressure ulcers in mice using a combination of photoactivated collagen-embedded compounds plus 455 nm diode laser irradiation compared to irradiation alone or no treatment. The antibacterial effect of the combined therapy increased with successive treatments, report the authors in the article "Preliminary Assessment of Photoactivated Antimicrobial Collagen on Bioburden in a Murine Pressure Ulcer Model."

In the article "Wavelength and Bacterial Density Influence the Bactericidal Effect of Blue Light on Methicillin-Resistant Staphylococcus aureus (MRSA)," Violet Bumah, PhD and coauthors compared the bacteria-killing power of 405 nm versus 470 nm light on colonies of resistant Staph aureus and how the density of the bacterial colonies could limit light penetration and the bactericidal effects of treatment.



INFORMATION:

About the Journal

Photomedicine and Laser Surgery is an authoritative peer-reviewed online journal published monthly. The Journal is under the leadership of Editor-in-Chief Raymond J. Lanzafame, MD, MBA and Co-Editor-in-Chief Chukuka S. Enwemeka, PhD. The Journal provides rapid publication of cutting-edge techniques and research in phototherapy, low level laser therapy (LLLT), and laser medicine and surgery. Reports cover a range of basic and clinical research and procedures in medicine, surgery, and dentistry, focusing on safety issues, new instrumentation, optical diagnostics, and activities related to the understanding and applications of biophotonics in medicine. Photomedicine and Laser Surgery is the official journal of the World Association for Laser Therapy (WALT), North American Association for Laser Therapy (NAALT), and an official journal of the World Federation for Laser Dentistry (WFLD) Tables of content and a free sample issue may be viewed on the Photomedicine and Laser Surgery website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in promising areas of science and biomedical research, including Journal of Laparoendoscopic & Advanced Surgical Techniques and Journal of Gynecologic Surgery. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Mary Ann Liebert, Inc.
140 Huguenot St., New Rochelle, NY 10801-5215
Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101
http://www.liebertpub.com



ELSE PRESS RELEASES FROM THIS DATE:

Health care costs steadily increase with body mass

2013-12-16
Health care costs steadily increase with body mass DURHAM, N.C. – Researchers at Duke Medicine are giving people another reason to lose weight in the new year: obesity-related illnesses are expensive. According to a study published in the journal ...

Swift satellite catches 100,000 new cosmic X-ray sources

2013-12-16
Swift satellite catches 100,000 new cosmic X-ray sources Astronomers from University of Leicester provide new insights into cosmic phenomena An international team led from the University of Leicester has published a major list of celestial X-ray sources in ...

Regenstrief and IU investigators identify first biomarker linked to delirium duration

2013-12-16
Regenstrief and IU investigators identify first biomarker linked to delirium duration INDIANAPOLIS -- Researchers from the Regenstrief Institute and the Indiana University Center for Aging Research have identified the first biomarker that appears to be linked to the ...

Study finds piece-by-piece approach to emissions policies can be effective

2013-12-16
Study finds piece-by-piece approach to emissions policies can be effective CAMBRIDGE, Mass. — Discussions on curbing climate change tend to focus on comprehensive, emissions-focused measures: a global cap-and-trade scheme aimed at controlling carbon, ...

SOFS take to water

2013-12-16
SOFS take to water Researchers at Berkeley Lab's Molecular Foundry create first soluble 2D supramolecular organic frameworks Supramolecular chemistry, aka chemistry beyond the molecule, in which molecules and molecular complexes are held together by ...

Penn-led team reduces toxicity associated with Lou Gehrig's disease in animal models

2013-12-16
Penn-led team reduces toxicity associated with Lou Gehrig's disease in animal models Amyotrophic lateral sclerosis, better known as Lou Gehrig's disease, is a devastating illness that gradually robs sufferers of muscle strength and eventually causes ...

SMA reveals giant star cluster in the making

2013-12-16
SMA reveals giant star cluster in the making W49A might be one of the best-kept secrets in our galaxy. This star-forming region shines 100 times brighter than the Orion nebula, but is so obscured by dust that very little visible or ...

Affordable Care Act offers opportunities to strengthen trauma systems

2013-12-16
Affordable Care Act offers opportunities to strengthen trauma systems Traumatic injuries are the leading cause of death and disability for people under the age of 45 and the fourth-leading cause of death for people of all ages. ...

Deep-sea corals record dramatic long-term shift in Pacific Ocean ecosystem

2013-12-16
Deep-sea corals record dramatic long-term shift in Pacific Ocean ecosystem Changes at the base of the food web in the North Pacific Subtropical Gyre, Earth's largest contiguous ecosystem, may be linked to warming and expansion of open ocean gyres Long-lived ...

Researchers split water into hydrogen, oxygen using light, nanoparticles

2013-12-16
Researchers split water into hydrogen, oxygen using light, nanoparticles Technology potentially could create a clean, renewable source of energy Researchers from the University of Houston have found a catalyst that can quickly generate hydrogen from water using sunlight, ...

LAST 30 PRESS RELEASES:

Ancien DNA pushes back record of treponemal disease-causing bacteria by 3,000 years

Human penis size influences female attraction and male assessment of rivals

Scientists devise way to track space junk as it falls to earth

AI is already writing almost one-third of new software code

A 5,500-year-old genome rewrites the origins of syphilis

Tracking uncontrolled space debris reentry using sonic booms

Endogenous retroviruses promote early human zygotic development

Malicious AI swarms pose emergent threats to democracy

Progenitor cells in the brain constantly attempt to produce new myelin-producing brain cells

Quantum measurements with entangled atomic clouds

Mayo Clinic researchers use AI to predict patient falls based on core density in middle age

Moffitt study develops new tool to predict how cancer evolves

National Multiple Sclerosis Society awards Dr. Manuel A. Friese the 2025 Barancik Prize for Innovation in MS Research

PBM profits obscured by mergers and accounting practices, USC Schaeffer white paper shows

Breath carries clues to gut microbiome health

New study links altered cellular states to brain structure

Palaeontology: Ancient giant kangaroos could hop to it when they needed to

Decoded: How cancer cells protect themselves from the immune system

ISSCR develops roadmap to accelerate pluripotent stem cell-derived therapies to patients

New study shows gut microbiota directly regulates intestinal stem cell aging

Leading cancer deaths in people younger than 50 years

Rural hospital bypass by patients with commercial health insurance

Jumping giants: Fossils show giant prehistoric kangaroos could still hop

Missing Medicare data alters hospital penalties, study finds

Experimental therapy targets cancer’s bodyguards, turning foe to friend to eliminate tumors

Discovery illuminates how inflammatory bowel disease promotes colorectal cancer

Quality and quantity? The clinical significance of myosteatosis in various liver diseases

Expert consensus on clinical applications of fecal microbiota transplantation for chronic liver disease (2025 edition)

Insilico Medicine to present three abstracts at the 2026 Crohn’s & Colitis Congress highlighting clinical, preclinical safety, and efficacy data for ISM5411, a novel gut-restricted PHD1/2 inhibitor fo

New imaging technology detects early signs of heart disease through the skin

[Press-News.org] Blue light phototherapy kills antibiotic-resistant bacteria, according to new studies